But the election of a female head at Ireland’s oldest and most prestigious university due to be picked from an all-female short list of three senior scholars on April 7 will be the most momentous female appointment so far.
“We’ve seen a very significant transformation with the appointment of three female leaders in the past year, but we need to keep pushing for further improvements across the sector,” said Orla Feely, vice president for research at University College Dublin, who has backed the recently announced Science Foundation Ireland strategy that would seek to ensure that 35 percent of annual principal investigator grants go to women.
Immune system’s T cells can mount attacks against many coronavirus targets even on new variants, LJI says
An electron micrograph shows SARS-CoV-2 particles isolated from a patient.
(National Institute of Allergy and Infectious Diseases)
By La Jolla Institute for Immunology
Jan. 27, 2021 4:11 PM PT
A new study led by scientists at the La Jolla Institute for Immunology suggests that T cells try to fight SARS-CoV-2, the coronavirus that causes COVID-19, by targeting a broad range of sites on the virus. By attacking the virus from many angles, the body has the tools to potentially recognize different SARS-CoV-2 variants.
The new research, published Jan. 27 in
Study provides a detailed look at vulnerable sites on SARS-CoV-2
A new study led by scientists at La Jolla Institute for Immunology (LJI) suggests that T cells try to fight SARS-CoV-2 by targeting a broad range of sites on the virus beyond the key sites on the virus s spike protein. By attacking the virus from many angles, the body has the tools to potentially recognize different SARS-CoV-2 variants.
The new research, published January 27, 2021 in
Cell Report Medicine, is the most detailed analysis so far of which proteins on SARS-CoV-2 stimulate the strongest responses from the immune system s helper CD4+ T cells and killer CD8+ T cells.
E-Mail
IMAGE: Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. view more
Credit: NIAID
LA JOLLA A new study led by scientists at La Jolla Institute for Immunology (LJI) suggests that T cells try to fight SARS-CoV-2 by targeting a broad range of sites on the virus beyond the key sites on the virus s spike protein. By attacking the virus from many angles, the body has the tools to potentially recognize different SARS-CoV-2 variants.
The new research, published January 27, 2021 in
Cell Report Medicine, is the most detailed analysis so far of which proteins on SARS-CoV-2 stimulate the strongest responses from the immune system s helper CD4+ T cells and killer CD8+ T cells.